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Abstract
Background: Hyperperfusion syndrome (HPS) following carotid angioplasty with stenting (CAS) is associated with
significant morbidity and mortality. At present, there are no reliable parameters to predict HPS. The aim of this study was to
clarify whether perfusion computed tomography (CT) is a feasible and reliable tool in predicting HPS after CAS.
Methodology/Principal Findings: We performed a retrospective case-control study of 54 patients (11 HPS patients and 43
non-HPS) with unilateral severe stenosis of the carotid artery who underwent CAS. We compared the prevalence of vascular
risk factors and perfusion CT parameters including regional cerebral blood volume (rCBV), regional cerebral blood flow
(rCBF), and time to peak (TTP) within seven days prior to CAS. Demographic information, risk factors for atherosclerosis, and
perfusion CT parameters were evaluated by multivariable logistic regression analysis. The rCBV index was calculated as
[(ipsilateral rCBV - contralateral rCBV)/contralateral rCBV], and indices of rCBF and TTP were similarly calculated. We found
that eleven patients had HPS, including five with intracranial hemorrhages (ICHs) of whom three died. After a comparison
with non-HPS control subjects, independent predictors of HPS included the severity of ipsilateral carotid artery stenosis, 3-
hour mean systolic blood pressure (3 h SBP) after CAS, pre-stenting rCBV index .0.15 and TTP index .0.22.
Conclusions/Significance: The combination of severe ipsilateral carotid stenosis, 3 h SBP after CAS, rCBV index and TTP
index provides a potential screening tool for predicting HPS in patients with unilateral carotid stenosis receiving CAS. In
addition, adequate management of post-stenting blood pressure is the most important treatable factor in preventing HPS
in these high risk patients.
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Introduction
Carotid angioplasty with stenting (CAS) is considered less
invasive than carotid endarterectomy (CEA) and is an acceptable
alternative treatment for carotid artery stenosis [1–3]. Major
complications with CAS include cerebral embolism, vessel
dissection, and hyperperfusion syndrome (HPS) [4–6]. In 1978,
Spetzler et al. first described the phenomenon of hyperperfusion
following surgical resection of arteriovenous malformations [7]. In
1981, Sundt et al. described this phenomenon in patients receiving
carotid endarterectomy (CEA), in which a triad of signs and
symptoms including ipsilateral throbbing headache, transient focal
seizures, and intracranial hemorrhage defined HPS [8]. HPS often
results in significant morbidity and mortality; therefore, identifying
patients who are most at risk for HPS after CAS is crucial. [5,6]
Although quantitative measurement of regional cerebral blood
flow (rCBF) provided by positron emission tomography (PET)
[9,10] and xenon-enhanced computed tomography (CT) [11] can
be considered the gold standard for assessment of cerebral
perfusion, the availability of these imaging studies is limited.
Perfusion CT has also been used to assess cerebral perfusion after
brain infarct [9,10]. The aim of this study was to clarify whether
perfusion CT is a feasible and reliable tool in predicting HPS after
CAS.
Methods
Objectives
The aim of this study was to determine if perfusion CT can
reliably predict HPS after CAS. The degree of carotid artery
stenosis was measured according to the methods of the North
American Symptomatic Carotid Endarterectomy Trial (NASCET)
[12], and a successful procedure was defined as a post-stent
luminal narrowing of less than 30%. Patients with neurological
deficits that related to the hemisphere perfused by the stenotic
carotid artery (i.e., the ipsilateral side) were diagnosed with
symptomatic carotid artery stenosis. Patients with ipsilateral
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focal neurologic deficits after CAS were diagnosed with HPS
[5,8,13–14]. Cerebral diffusion-weighted MRI was performed to
rule out embolic stroke after CAS. In addition, 3-hour SBP (3 h
SBP) after CAS was defined as the mean SBP within 3 hours after
CAS.
Participants
We retrospectively reviewed consecutive patients with unilater-
ally significant (.60%) carotid artery stenosis (both symptomatic
and asymptomatic), who underwent CAS in Linkou Chang Gung
Memory Hospital from April 2003 to September 2008. We
conducted a matched case control study. Patients in the control
group were age and sex matched. In addition, the degree of
contralateral stenosis had to be below 50% with minimal
difference (610%) between two groups. Patients with HPS (case
subjects) and patients without HPS (control subjects) were
retrospectively recruited in the same period. A total of 54 subjects
(11 HPS and 43 non-HPS) were included to the study, and all
participants were interviewed and examined by one neurologist.
All patients were informed about the best medical treatment and
both invasive therapies (CEA and CAS), but all 54 patients
decided to receive CAS.
Before CAS, the patients were pretreated with 100 mg/d of
aspirin and 75 mg/d of clopidogrel for at least four days. In
addition, all patients underwent perfusion CT within one week
prior to the procedure. A neurologist evaluated all the patients
before and after CAS to determine whether any patients showed
neurological signs or symptoms. After CAS, the patients were
transferred to the intensive care unit and BP was monitored
hourly. The demographic information, atherosclerotic risk factors,
associated conditions and indices of rCBV, rCBF and TTP on
perfusion CT were collected for further analysis.
Description of Procedures undertaken: Perfusion CT
Cerebral perfusion CT was performed on a CT unit equipped
with a 16-detector array (SOMATOM Sensation 16, Siemens AG,
Forchheim, Germany). After nonenhanced CT of the whole brain,
two adjacent 12-mm-thick sections were selected at the level of the
third ventricle and basal ganglia that covered the anterior, middle,
and posterior cerebral artery territories. A bolus of 40 mL of
nonionic iodinated contrast medium (350 mg/dL, Omnipaque
TM
(iohexol), GE healthcare, Ireland) was injected at a rate of 5 mL/s
into an antecubital vein with a power injector. Five seconds after
the injection, dynamic (continuous) scanning was initiated with the
following technique: 80 kVp, 120 mA, four 24-mm-thick sections,
and 0.5 seconds per rotation for 40 seconds. The time delay
before the contrast material reached the brain parenchyma
allowed for the acquisition of nonenhanced baseline images. The
5-mm-thick sections were reformatted into two 12-mm-thick
sections. Therefore, each section was composed of 80 sequential
images (40 prospective and 44 retrospective images). There were a
total of 160 images (2 adjacent 12 mm sections) with a 0.5 second
time resolution. For all scans, a 25 cm field of view was used, and
scans were reconstructed with a matrix of 512*512 pixels. Relative
values of regional cerebral blood flow (rCBF), regional cerebral
blood volume (rCBV), and time to peak (TTP) (Figs. 1B, 1C, and
1D), based on the CT time attenuation curves for each pixel, were
generated on the scanner’s workstation using the software
provided by the manufacturer (Syngo Somaris/5 VB 10B,
Siemens Medical Solutions, Germany). The TTP index was
calculated as [(ipsilateral TTP - contralateral TTP)/contralateral
TTP]. The indices of rCBV and rCBF were also calculated in the
same manner.
Ethics
This study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the
Institutional Review Board of Chang Gung Memorial Hospital.
All patients provided written informed consent for the collection of
samples and subsequent analysis.
Statistical methods
Statistical analysis was performed using SPSS software for
Windows version 16.0 (SPSS Inc, Chicago, IL). A two-tailed
Student’s t-test for continuous variables and chi-square test (or
Fisher’s exact test whenever appropriate) for discrete variables
(Tables 1 and 2) were performed to compare the study
characteristics associated with positive versus negative variables
between HPS and non-HPS. To assess the ability of perfusion CT
parameters to distinguish high-risk participants who actually had
HPS from low-risk patients, we calculated the area under the
receiver operating characteristic (AUROC) curve of CT perfusion
parameters, which assessed the discrimination of the function.
Sample size calculation for logistic regression is a complex
problem, but Peduzzi [15] recommended that the smaller of the
classes of the dependent variable have at least 10 events per
parameter in the model. We calculated that we would obtain
acceptable statistical power from this study if the sample size was
greater than 50. Our total sample size was 54. Three multivariable
logistic regression analyses were performed to identify which
variables were independently associated with HPS. Our aim was
not to develop a prediction model primarily based on preoperative
clinical characteristics, but to assess whether a perfusion CT
parameter was associated with HPS. Therefore, as is common in
prediction research, we defined an independent association if the
odds ratio (OR) had a value of p,0.05. Starting with a model that
included preoperative clinical variables (based on their known or
potential confounding effects on the relationship of HPS from the
literature) [4,5,9,10,13] or initial univariate analyses with signif-
icant results (p,0.05), the insignificant (p.0.05) ones were
excluded. This model was extended with the univariate significant
TTP index. Finally, this last model was extended with the rCBV
index to evaluate whether it further contributed to the clinical
variables and TTP index in predicting HPS.
Results
A total of 54 patients (11 HPS patients and 43 non-HPS) with
unilateral severe stenosis of the carotid artery underwent CAS.
The distribution of demographic data, clinical characteristics and
outcomes are shown in Table 1. Among the 11 patients with HPS,
three died due to massive ICH after CAS. Patients in the HPS
group had a greater severity of carotid artery stenosis, larger
balloon pressure and higher 3 h SBP after CAS (p,0.05, Table 1)
compared to the non-HPS group. There were no significant
differences in the distribution of atherosclerotic risk factors or
clinical status between patients with and without HPS.
Imaging analysis was performed on all 54 patients using regions
of interest (ROIs) drawn on the perfusion CT scans by an
experienced neuroradiologist (S.C.C.). An ROI was drawn on
each hemisphere in each of the 54 patients for a total of 108 ROIs
generated from the ipsilateral middle cerebral artery (MCA)
territory and 108 ROIs from the contralateral MCA territory. The
mean values of the perfusion parameters from the ROIs are shown
in Table 2. While the mean rCBV and mean TTP were both
significantly higher in the HPS patients compared to the non-HPS
patients (all p,0.05), there was no significant difference between
the two groups with regards to rCBF.
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operating characteristic (AUROC) curve, the thresholds for the
discrimination of HPS and non-HPS were estimated to be
approximately 0.15 for the rCBV index (AUROC=0.74;
confidence interval (CI)=0.71–0.93) and 0.22 for the TTP index
(AUROC=0.65, CI=0.62–0.91) if each parameter was used as a
single discriminator (Figures 2A and 2B). Furthermore, the rCBV
index tended to be more efficient in predicting HPS compared to
the TTP index, although this difference did not reach statistical
significance.
Stepwise multivariable logistic regression models (Table 3) for
predicting HPS were devised to assess the incremental contribu-
tion of perfusion parameters to the clinical evaluation. For HPS,
ipsilateral carotid stenosis and 3 h SBP after CAS were used for
the clinical model (chi-square=19.4, p=0.03). The addition of the
TTP index increased the power of the model (increment of chi-
square=4.12, df=1, p=0.03). The addition of the rCBV index
further increased the power of the model (increment of chi-
square=3.07, df=1, p=0.04), even though the TTP index was
not significantly associated with HPS.
Discussion
To the best of our knowledge, this is first time HPS has been
characterized in a subgroup of patients with unilateral severe
carotid artery stenosis using a combination of clinical character-
istics and perfusion CT parameters. The independent patient
characteristics were ipsilateral carotid artery stenosis, balloon
pressure and the 3 h SBP after CAS. The present study also
evaluated whether the TTP index and rCBV index were
independently associated with HPS after CAS. As shown in
Table 3, we found that Model 3, which included a TTP index
.0.22 and an rCBV index .0.15, was statistically superior to the
other two models in predicting HPS in our patients. These
Figure 1. A 68-year-old man with a right hemispheric ischemic stroke. (A) Pre-stentingdigital subtractionangiography reveals a 76% stenosis
of the left internal carotid artery. A perfusion computed tomography (CT) study demonstrates a relatively decreased regional cerebral blood volume
(rCBV)(B),decreasedregionalcerebralbloodflow(rCBF)(C),andincreasedtimetopeak (TTP)(D)intheleft hemisphere.Thestentingprocedureshows a
25% residual stenosis of the carotid artery (E). The rainbow on the right display reveals a range of rCBV from 22 to 60 ml/100 gm; rCBF from 22t o
100 ml/100 gm/min and TTP from 22 to 200 deciseconds. The patient suffered a sudden loss of consciousness two hours after stenting, and follow-up
brain CT reveals a massive hematoma of the left basal ganglia, left frontal and temporal lobes with rupture into the ventricles (F).
doi:10.1371/journal.pone.0019886.g001
Table 1. Demographic data of patients with and without
hyperperfusion syndrome.
Without HPS (n=43) With HPS (n=11)
Atherosclerotic risk factors, n (%)
Age (years) 71.1 (4.6; 60–89) 71.5 (5.0; 81–95)
Gender (male) 39 (90.7) 10 (90.0)
Hypertension 34 (79.1) 8 (72.7)
Diabetes mellitus 13 (30.2) 4 (36.4)
Dyslipidemia 17 (39.5) 5 (45.5)
Smoking 23 (53.5) 6 (54.5)
TIA 6 (14.0) 1 (9.1)
Stroke 26 (60.5) 7 (63.6)
CAD 13 (30.2) 3 (27.3)
Carotid artery stenosis and procedure related
Ipsilateral CA
stenosis (%)
76.0 (8.4; 60–89) 85.4 (9.4; 81–95)*
Contralateral CA
stenosis (%)
35.9 (3.7; 25–49) 42.4 (3.5; 30–49)
Residual CA stenosis (%) 19.6 (12.8; 0–30) 18.3 (6.9; 5–26)
Balloon pressure 9.8 (3.0; 6–18) 12.9 (3.4; 6–16)**
Pre-stent SBP 130.1 (12.9; 105–165) 131.8 (13.5; 109–149)
Post-stent 1 h SBP 132.3 (24.3; 87–183) 146.3 (18.1; 121–166)
Post-stent 3 h SBP 132.1 (22.4; 77–187) 169.7 (22.6; 130–208)**
Post-stent 6 h SBP 130.3 (20.9; 81–183) 139.1 (26.9; 104–198)*
Post-stent 24 h SBP 126.7 (14.6; 108–153) 129.6 (13.8; 102–142)
Continuous data are displayed as mean (SD; range) and discrete data are
presented as count (%).
*p,0.05;
**p,0.001;
HPS: hyperperfusion syndrome; TIA: transient ischemic attack; CAD: coronary
artery disease, CA: carotid artery; SBP: systolic blood pressure.
doi:10.1371/journal.pone.0019886.t001
Table 2. Comparison of perfusion CT parameters between
patients with and without hyperperfusion syndrome.
Without HPS (n=43) With HPS (n=11)
Perfusion CT parameters
rCBV index (%) 0.04 (0.71) 0.16 (0.08)**
rCBF index (%) 0.04 (0.14) 20.96 (0.2)
TTP index (%) 0.06 (0.23) 0.29 (0.37)**
Continuous data are displayed as mean (SD); p,0.05;
**p,0.001;
CT: computed tomography; HPS: hyperperfusion syndrome; rCBF index:
regional cerebral blood flow index=[(ipsilateral rCBF2contralateral rCBF)/
contralateral rCBF]; rCBV index: regional cerebral blood volume
index=[(ipsilateral rCBV2contralateral rCBV)/contralateral rCBV]; TTP index:
time to peak index=[(ipsilateral TTP2contralateral TTP)/contralateral TTP].
doi:10.1371/journal.pone.0019886.t002
Cerebral Hyperperfusion Syndrome
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19886associations persisted after including the preoperative patient
characteristics in addition to a TTP index .0.22. These results
suggest that a model that includes the clinical characteristics, a
TTP index .0.22 and an rCBV index .0.15 may be useful in the
predicting HPS in patients with unilateral carotid stenosis
undergoing CAS.
The potential HPS risk factors following CEA include age,
hypertension, severity of ipsilateral carotid stenosis, and presence
of contralateral stenosis or occlusion [4,6,12,13,16–18]. Owing to
the study design and hypothesis, we controlled for age, gender and
contralateral carotid artery stenosis ,50%. In our retrospective
study, only the severity of ipsilateral carotid artery stenosis, balloon
pressure and the 3 h SBP after CAS were significant when
comparing the non-HPS and HPS groups. High blood pressure is
known to be a significant risk factor for HPS after carotid
intervention [16,19–20]. The difference between systemic blood
pressure and venous back pressure determines cerebral perfusion
pressure [17]. Reperfused blood flow in a severely hypoperfused
vascular bed leads to profound vasodilatation and increased
permeability, which can be augmented by increased BP [16].
Therefore, an ominous elevation of BP may increase cerebral
perfusion pressure and predispose to ICH during reperfusion after
carotid recanalization. Our patients who had a higher 3 h SBP
after CAS had a significantly increased incidence of HPS
Figure 2. rCBV (A) and TTP (B) in HPS and non-HPS patients. From univariate discrimination analysis by receiver operating characteristic (ROC)
curves, the threshold levels for the best discrimination of HPS and non-HPS are 1.15 and 1.22 for rCBV and TTP, respectively.
doi:10.1371/journal.pone.0019886.g002
Table 3. Multivariable logistic regression analysis of hyperperfusion syndrome after carotid stenting.
OR (95% CI)
Model 1
Clinical characteristics
Model 2
Clinical characteristics
+ TTP index
Model 3
Clinical characteristics
+ TTP index
+ rCBV index
Clinical characteristics
Age 1.13 (0.93–1.43) 1.18 (0.9–1.56) 1.18 (0.9–1.56)
Hypertension 0.39 (0.05–3.09) 0.15 (0.01–1.68) 0.15 (0.01–1.68)
Ipsilateral stenosis 1.25 (1.04–1.5)* 1.24 (1.03–1.49)* 1.23 (1.01–1.50)*
Contralateral stenosis 1.03 (0.99–1.05) 1.02 (0.99–1.06) 1.02 (0.99–1.06)
Balloon pressure 1.12 (0.81–1.56) 1.24 (0.86–1.77) 1.24 (0.86–1.77)
3 h SBP after CAS 2.18 (1.3–3.56)* 1.45 (1.08–1.93)* 1.45 (1.37–1.53)*
Perfusion CT parameters
TTP index.0.22 ---------- 4.27 (1.11–47.84)* 3.44 (0.89–53.36)
rCBV index.0.15 ---------- ---------- 6.89 (1.08–43.91)*
DX
2 ---------- 4.12 (df=1)*
from Model 1
3.07 (df=1)*
from Model 2
AUROC (95%CI) 0.64 (1.12–2.87) 0.72 (1.24–2.89) 0.74 (0.64–0.89)
*p,0.05;
**p,0.001;
OR: odds ratio, CI: confidence interval, 3 h SBP after CAS: mean systolic blood pressure after carotid artery stenting within 3 hours, TTP index: time to peak
index=[(ipsilateral TTP2contralateral TTP)/contralateral TTP], rCBV index: regional cerebral blood volume index=[(ipsilateral rCBV2contralateral rCBV)/contralateral
rCBV], Dx2 (increment of chi-square) at steps 2 and 3 represent the statistical significance of any improvement in prediction as a result of that variable being entered
into the model, AUROC: area under the receiver operating characteristic curve.
doi:10.1371/journal.pone.0019886.t003
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Therefore, in high risk patients, a more aggressive control of SBP
after CAS should decrease the incidence of HPS.
Cerebral perfusion can be measured by various tools including
PET [9,10], magnetic resonance imaging [21], single photon
emission computed tomography [22] and xenon CT [11]. Of these
techniques, PET is the current standard of reference for assessing
cerebral blood flow and brain metabolism [9,10]. Recently,
perfusion CT has been shown to correlate well with the PET data.
Previous investigations have also indicated that perfusion CT
parameters such as TTP, rCBV, and rCBF are useful both for the
delineation of hypoperfused brain tissue in acute stroke and for
predicting outcome [23]. In recent years, perfusion CT has also
been used to evaluate chronic ischemia associated with hemody-
namic compromise resulting from high grade carotid stenosis
[24,25]. However, although perfusion CT can obtain quantitative
data regarding brain perfusion, previous studies [26] have shown
that absolute measurements are unable to provide accurate results
due to limitations of the underlying model. In addition, the choice
of arterial input function (AIF) and selection of ROIs are operator
dependent [27], affecting consistency among different investiga-
tors. To overcome this pitfall, our perfusion parameters were semi-
quantitatively corrected, by using as a reference, data from the
mirror image regions in the contralateral hemisphere [28]. In the
current study, we also used semi-quantitative indices of TTP,
rCBF and rCBV as the basis of comparison between the two
hemispheres, with the assumption that the perfusion of the
contralateral hemisphere was normal. For this reason we focused
only on patients with unilateral carotid stenosis.
Even with severe carotid stenosis or occlusion, distal brain
perfusion and rCBF may remain normal or be only mildly
decreased, with or without increasing rCBV, if collateral
circulation is adequate [29]. TTP can indicate the local arrival
of the contrast bolus, and in particular, depict the location and
extent of ischemia [30,31]. Blood flow via collateral routes may
take a longer time to reach the brain than via the more normal,
direct arterial routes, thus leading to delays in TTP [29].
According to the mathematical relationship, TTP=rCBV/rCBF,
the synergistic effect of decreased rCBF and increased rCBV will
result in a large change in TTP value. Furthermore, TTP may be
more sensitive than rCBV or rCBF in detecting the presence of
altered cerebral hemodynamics, especially in acute stroke and
cerebrovascular occlusive disease [32,33]. Our findings support
previous reports [34,35] and suggest a model that can predict the
development of HPS using clinical characteristics and TTP index.
In addition, this model is statistically superior in performance to
other models that are based on clinical variables alone.
We also found that there was a significant increase in TTP as
the rCBV index was added to Model 3, even if the TTP index was
statistically insignificant. These results were substantiated by a
recent report by Trojanowska et al. [36]. Similarly, in a study by
Tseng et al. [37] using GE perfusion CT workstation those
patients who developed HPS after CAS showed a prolonged
dMTT of more than 3 seconds. These patients also showed a
tendency of prolonged rCBV, though statistically non-significant.
In other words, even though TTP index prolongation was
remarkable, the rCBV index increased at the same time. This
finding suggests a failure of autoregulation which results in
maximal dilation of cerebral arterioles over time, with subsequent
loss of the ability of the arteriole to constrict when normal
perfusion pressure is restored. Under such conditions, luxury
perfusion after successful CAS may lead to circulatory overload
followed by hyperperfusional injury and the potential development
of HPS. Consequently, those patients with increased rCBV and
TTP are at higher risk of developing HPS, compared to groups
with normal rCBV values.
Limitations
Our study had several limitations. First, since contrast media
must be administered as a bolus, imaging can be performed only
once per imaging session in a first-pass bolus study. Although the
quality of an intravenous bolus depends on many physiologic
parameters, a flow rate of 6–10 mL/s appears sufficient to obtain
a rather narrow distribution of TTP values in the healthy
hemisphere [38]. Because we were able to achieve a flow rate of
only 5 mL/s in our patients, our TTP values had a broad range.
We were also limited, using perfusion CT, to single-section
measurements. Ideally, a multi-section acquisition that covers a
larger volume of the brain would be desirable. Although a single
section technique is capable of localizing the infarction, it is not
able to show the extent of the infarction in all three dimensions.
This does not necessarily imply, however, that perfusion CT is
meaningless in cases of chronic ischemia with hemodynamic
compromise. A future perfusion CT study with a larger number of
patients is warranted to confirm our findings in cases of chronic
ischemia with hemodynamic compromise. Finally, the small case
number and low incidence of HPS in our study limits its
application. Larger prospective studies of CAS are necessary to
confirm our results.
In conclusion, the combination of clinical characteristics
coupled with rCBV and TTP indices are a potential screening
tool in the pre-stent evaluation for HPS in patients with unilateral
severe carotid artery stenosis. In addition, adequate management
of post-stenting BP is the most important treatable factor in
preventing HPS in high risk patients.
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